[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Report

August 2018 | 159 pages | ID: 2281BCFEF98EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Liposome Drug Delivery (Liposomes Drug Delivery) market for 2018-2023.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 3.6 billion USD in 2020 at a CAGR of 8.57%.

North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.

Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site.

Finally, liposomal drugs exhibit reduced toxicities and retain enhanced efficacy compared with free complements. Based on the pharmaceutical applications and available products, we can say that liposomes have definitely established their position in modern delivery systems.

Over the next five years, LPI(LP Information) projects that Liposome Drug Delivery (Liposomes Drug Delivery) will register a 10.0% CAGR in terms of revenue, reach US$ 4260 million by 2023, from US$ 2400 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Drug Delivery (Liposomes Drug Delivery) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Other
Segmentation by application:
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Other
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Johnson & Johnson
  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Luye Pharma
  • Sigma-Tau Group
  • Fudan-Zhangjiang
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Kingond Pharm
  • Spectrum Pharmaceuticals
  • Shanghai New Asia
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Liposome Drug Delivery (Liposomes Drug Delivery) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Liposome Drug Delivery (Liposomes Drug Delivery) market by identifying its various subsegments.
  • Focuses on the key global Liposome Drug Delivery (Liposomes Drug Delivery) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Liposome Drug Delivery (Liposomes Drug Delivery) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Liposome Drug Delivery (Liposomes Drug Delivery) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2013-2023
  2.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption CAGR by Region
2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type
  2.2.1 Liposomal Doxorubicin
  2.2.2 Liposomal Amphoteracin B
  2.2.3 Liposomal Paclitaxel
  2.2.4 Other
2.3 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
  2.3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
  2.3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Type (2013-2018)
2.4 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
  2.4.1 Fungal Infection Therapy
  2.4.2 Cancer & Tumor Therapy
  2.4.3 Other
2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
  2.5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
  2.5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value and Market Share by Application (2013-2018)
  2.5.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Application (2013-2018)

3 GLOBAL LIPOSOME DRUG DELIVERY (LIPOSOMES DRUG DELIVERY) BY PLAYERS

3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players
  3.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Players (2016-2018)
  3.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players (2016-2018)
3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players
  3.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Players (2016-2018)
  3.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players (2016-2018)
3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Players
3.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 LIPOSOME DRUG DELIVERY (LIPOSOMES DRUG DELIVERY) BY REGIONS

4.1 Liposome Drug Delivery (Liposomes Drug Delivery) by Regions
  4.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions
  4.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value by Regions
4.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
4.3 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
4.4 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth
4.5 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth

5 AMERICAS

5.1 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries
  5.1.1 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018)
  5.1.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018)
5.2 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
5.3 Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries
  6.1.1 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018)
  6.1.2 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018)
6.2 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
6.3 APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
  7.1.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018)
  7.1.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018)
7.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
7.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
  8.1.1 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018)
8.2 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type
8.3 Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Distributors
10.3 Liposome Drug Delivery (Liposomes Drug Delivery) Customer

11 GLOBAL LIPOSOME DRUG DELIVERY (LIPOSOMES DRUG DELIVERY) MARKET FORECAST

11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2018-2023)
11.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Regions
  11.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Regions (2018-2023)
  11.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Type
11.8 Global Liposome Drug Delivery (Liposomes Drug Delivery) Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Johnson & Johnson
  12.1.1 Company Details
  12.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.1.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Johnson & Johnson News
12.2 Gilead Sciences
  12.2.1 Company Details
  12.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.2.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Gilead Sciences News
12.3 Pacira
  12.3.1 Company Details
  12.3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.3.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pacira News
12.4 Sun Pharmaceutical
  12.4.1 Company Details
  12.4.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.4.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Sun Pharmaceutical News
12.5 Luye Pharma
  12.5.1 Company Details
  12.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Luye Pharma News
12.6 Sigma-Tau Group
  12.6.1 Company Details
  12.6.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sigma-Tau Group News
12.7 Fudan-Zhangjiang
  12.7.1 Company Details
  12.7.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.7.3 Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Fudan-Zhangjiang News
12.8 Teva Pharmaceutical
  12.8.1 Company Details
  12.8.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.8.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Teva Pharmaceutical News
12.9 CSPC
  12.9.1 Company Details
  12.9.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.9.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 CSPC News
12.10 Novartis
  12.10.1 Company Details
  12.10.2 Liposome Drug Delivery (Liposomes Drug Delivery) Product Offered
  12.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Novartis News
12.11 Kingond Pharm
12.12 Spectrum Pharmaceuticals
12.13 Shanghai New Asia

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Liposome Drug Delivery (Liposomes Drug Delivery)
Table Product Specifications of Liposome Drug Delivery (Liposomes Drug Delivery)
Figure Liposome Drug Delivery (Liposomes Drug Delivery) Report Years Considered
Figure Market Research Methodology
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth Rate 2013-2023 ($ Millions)
Table Liposome Drug Delivery (Liposomes Drug Delivery) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Liposomal Doxorubicin
Table Major Players of Liposomal Doxorubicin
Figure Product Picture of Liposomal Amphoteracin B
Table Major Players of Liposomal Amphoteracin B
Figure Product Picture of Liposomal Paclitaxel
Table Major Players of Liposomal Paclitaxel
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Type (2013-2018) ($ million)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Type (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Type (2013-2018)
Figure Liposome Drug Delivery (Liposomes Drug Delivery) Consumed in Fungal Infection Therapy
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Fungal Infection Therapy (2013-2018) (K Units)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Fungal Infection Therapy (2013-2018) ($ Millions)
Figure Global Fungal Infection Therapy YoY Growth ($ Millions)
Figure Liposome Drug Delivery (Liposomes Drug Delivery) Consumed in Cancer & Tumor Therapy
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Cancer & Tumor Therapy (2013-2018) (K Units)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Cancer & Tumor Therapy (2013-2018) ($ Millions)
Figure Global Cancer & Tumor Therapy YoY Growth ($ Millions)
Figure Liposome Drug Delivery (Liposomes Drug Delivery) Consumed in Other
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Other (2013-2018) (K Units)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value by Application (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Application (2013-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Application (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Application (2013-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Players (2016-2018) (K Units)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players (2016-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players in 2016
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Players in 2017
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Players (2016-2018) ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players (2016-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players in 2016
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Market Share by Players in 2017
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Players (2016-2018)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Sale Price by Players in 2017
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution and Sales Area by Players
Table Players Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
Table Liposome Drug Delivery (Liposomes Drug Delivery) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Regions 2013-2018 (K Units)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Regions 2013-2018
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Regions 2013-2018
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value by Regions 2013-2018 ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Regions 2013-2018
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Regions 2013-2018
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2013-2018 (K Units)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value 2013-2018 ($ Millions)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2013-2018 (K Units)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value 2013-2018 ($ Millions)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2013-2018 (K Units)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value 2013-2018 ($ Millions)
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018) (K Units)
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries (2013-2018)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries in 2017
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018) ($ Millions)
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries (2013-2018)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries in 2017
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type (2013-2018) (K Units)
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type in 2017
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application (2013-2018) (K Units)
Table Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application in 2017
Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Canada Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Canada Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018) (K Units)
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries (2013-2018)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries in 2017
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018) ($ Millions)
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries (2013-2018)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries in 2017
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type (2013-2018) (K Units)
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type in 2017
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application (2013-2018) (K Units)
Table APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application in 2017
Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Korea Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Australia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Australia Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018) (K Units)
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries (2013-2018)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries in 2017
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018) ($ Millions)
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries (2013-2018)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries in 2017
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type (2013-2018) (K Units)
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type in 2017
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application (2013-2018) (K Units)
Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application in 2017
Figure Germany Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Germany Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure France Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure France Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure UK Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure UK Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Italy Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Italy Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Russia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Russia Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Spain Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Spain Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Countries in 2017
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share by Countries in 2017
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Type in 2017
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Application in 2017
Figure Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Israel Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Israel Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure Turkey Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure Turkey Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth 2013-2018 ($ Millions)
Table Liposome Drug Delivery (Liposomes Drug Delivery) Distributors List
Table Liposome Drug Delivery (Liposomes Drug Delivery) Customer List
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Forecast by Regions
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share Forecast by Regions
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Americas Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure APAC Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Europe Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Canada Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Canada Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Mexico Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Brazil Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Brazil Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Korea Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Southeast Asia Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Australia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Australia Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Germany Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Germany Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure France Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure France Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure UK Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure UK Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Italy Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Italy Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Russia Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Russia Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Spain Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Spain Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Egypt Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure South Africa Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Israel Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Israel Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure Turkey Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure Turkey Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Figure GCC Countries Liposome Drug Delivery (Liposomes Drug Delivery) Consumption 2018-2023 (K Units)
Figure GCC Countries Liposome Drug Delivery (Liposomes Drug Delivery) Value 2018-2023 ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share Forecast by Type (2018-2023)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share Forecast by Type (2018-2023)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share Forecast by Application (2018-2023)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Value Market Share Forecast by Application (2018-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Pacira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Luye Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Sigma-Tau Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Fudan-Zhangjiang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table CSPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Market Share (2016-2018)
Table Kingond Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai New Asia Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications